Prof. Ondřej Slabý, Ph.D.

Publications that are part of the Web of Science database, possibly also other publications chosen by authors.

2021

• Prochazkova, D; Borska, R; Fajkusova, L; Konecna, P; Hlouskova, E; Pavlovsky, Z; Slaby, O; Pospisilova, S, 2021: Two Novel Mutations in the JAG1 Gene in Pediatric Patients with Alagille Syndrome: The First Case Series in Czech Republic. DIAGNOSTICS 11(6), doi: 10.3390/diagnostics11060983
• Halamkova, J; Kazda, T; Pehalova, L; Gonec, R; Kozakova, S; Bohovicova, L; Slaby, O; Demlova, R; Svoboda, M; Kiss, I, 2021: The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients. FRONTIERS IN ONCOLOGY 10, doi: 10.3389/fonc.2020.573394
• Papez, J; Starha, J; Zerhau, P; Pavlovska, D; Jezova, M; Jurencak, T; Slaba, K; Sterba, M; Kerekes, A; Merta, T; Haluskova, T; Palova, H; Slaby, O; Sterba, J; Jabandziev, P, 2021: Spindle Cell Hemangioma and Atypically Localized Juxtaglomerular Cell Tumor in a Patient with Hereditary BRIP1 Mutation: A Case Report. GENES 12(2), doi: 10.3390/genes12020220
• Halamkova, J; Kazda, T; Pehalova, L; Gonec, R; Kozakova, S; Bohovicova, L; Krakorova, DA; Slaby, O; Demlova, R; Svoboda, M; Kiss, I, 2021: Second primary malignancies in colorectal cancer patients. SCIENTIFIC REPORTS 11(1), doi: 10.1038/s41598-021-82248-7
• Drula, R; Pirlog, R; Trif, M; Slaby, O; Braicu, C; Berindan-Neagoe, I, 2021: circFOXO3: Going around the mechanistic networks in cancer by interfering with miRNAs regulatory networks. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1867(5), doi: 10.1016/j.bbadis.2020.166045
• Koleckova, M; Ehrmann, J; Bouchal, J; Janikova, M; Brisudova, A; Srovnal, J; Staffova, K; Svoboda, M; Slaby, O; Radova, L; Vomackova, K; Melichar, B; Veverkova, L; Kolar, Z, 2021: Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer. SCIENTIFIC REPORTS 11(1), doi: 10.1038/s41598-021-84350-2
• Capoor, MN; Konieczna, A; McDowell, A; Ruzicka, F; Smrcka, M; Jancalek, R; Maca, K; Lujc, M; Ahmed, FS; Birkenmaier, C; Dudli, S; Slaby, O, 2021: Pro-Inflammatory and Neurotrophic Factor Responses of Cells Derived from Degenerative Human Intervertebral Discs to the Opportunistic Pathogen Cutibacterium acnes. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22(5), doi: 10.3390/ijms22052347
• Andrasina, T; Juracek, J; Zavadil, J; Cechova, B; Rohan, T; Vesela, P; Paldor, M; Slaby, O; Goldberg, SN, 2021: Thermal Ablation and Transarterial Chemoembolization are Characterized by Changing Dynamics of Circulating MicroRNAs. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY 32(3), p. 403 - 411, doi: 10.1016/j.jvir.2020.10.024
• Kandimalla, R; Wang, W; Yu, F; Zhou, NX; Gao, F; Spillman, M; Moukova, L; Slaby, O; Salhia, B; Zhou, ST; Wang, X; Goel, A, 2021: OCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study. CLINICAL CANCER RESEARCH 27(15), p. 4277 - 4286, doi: 10.1158/1078-0432.CCR-21-0267
• Jabandziev, P; Kakisaka, T; Bohosova, J; Pinkasova, T; Kunovsky, L; Slaby, O; Goel, A, 2021: MicroRNAs in Colon Tissue of Pediatric Ulcerative Pancolitis Patients Allow Detection and Prognostic Stratification. JOURNAL OF CLINICAL MEDICINE 10(6), doi: 10.3390/jcm10061325
• Novak, J; Machackova, T; Krejci, J; Bienertova-Vasku, J; Slaby, O, 2021: MicroRNAs as theranostic markers in cardiac allograft transplantation: from murine models to clinical practice. THERANOSTICS 11(12), p. 6058 - 6073, doi: 10.7150/thno.56327
• Bohosova, J; Kubickova, A; Slaby, O, 2021: lncRNA PVT1 in the Pathogenesis and Clinical Management of Renal Cell Carcinoma. BIOMOLECULES 11(5), doi: 10.3390/biom11050664
• Dykova, I; Zak, J; Reichard, M; Souckova, K; Slaby, O; Bystry, V; Blazek, R, 2021: Histopathology of laboratory-reared Nothobranchius fishes: Mycobacterial infections versus neoplastic lesions. JOURNAL OF FISH DISEASES 44(8), p. 1179 - 1190, doi: 10.1111/jfd.13378
• Eid, M; Ostrizkova, L; Kunovsky, L; Brancikova, D; Kala, Z; Hlavsa, J; Janecek, P; Kosikova, I; Blazkova, M; Slaby, O; Mayer, J, 2021: Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma. NEOPLASMA 68(1), p. 1 - 9, doi: 10.4149/neo_2020_200408N372
• Machackova, T; Vychytilova-Faltejskova, P; Souckova, K; Laga, R; Androvic, L; Mixova, G; Slaby, O, 2021: Barriers in Systemic Delivery and Preclinical Testing of Synthetic microRNAs in Animal Models: an Experimental Study on miR-215-5p Mimic. PHYSIOLOGICAL RESEARCH 70(3), p. 481 - 487, doi: 10.33549/physiolres.934571
• Parimuchova, A; Dusatkova, LP; Kovac, L; Machackova, T; Slaby, O; Pekar, S, 2021: The food web in a subterranean ecosystem is driven by intraguild predation. SCIENTIFIC REPORTS 11(1), doi: 10.1038/s41598-021-84521-1
• Coscia, EC; Abutaleb, NS; Hostetter, B; Seleem, MN; Breur, GJ; McCain, RR; Crain, CJ; Slaby, O; Capoor, MN; McDowell, A; Ahmed, FS; Vijayanpillai, V; Narayanan, SK; Coscia, MF, 2021: Sheep as a Potential Model of Intradiscal Infection by the Bacterium Cutibacterium acnes. VETERINARY SCIENCES 8(3), doi: 10.3390/vetsci8030048

2020

• Jurj, A; Pop-Bica, C; Slaby, O; Stefan, CD; Cho, WC; Korban, SS; Berindan-Neagoe, I, 2020: Tiny Actors in the Big Cellular World: Extracellular Vesicles Playing Critical Roles in Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 21(20), doi: 10.3390/ijms21207688
• Lakomy, R; Kazda, T; Selingerova, I; Poprach, A; Pospisil, P; Belanova, R; Fadrus, P; Smrcka, M; Vybihal, V; Jancalek, R; Kiss, I; Muckova, K; Hendrych, M; Knight, A; Sana, J; Slampa, P; Slaby, O, 2020: Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable. DIAGNOSTICS 10(9), doi: 10.3390/diagnostics10090676
• Kondelova, A; Alburquerque-Gonzalez, B; Vychytilova-Faltejskova, P; Garcia-Solano, J; Prochazka, V; Kala, Z; Perez, F; Slaby, O; Conesa-Zamora, P, 2020: miR-181a-2*expression is different amongst carcinomas from the colorectal serrated route. MUTAGENESIS 35(3), p. 233 - 241, doi: 10.1093/mutage/gez039
• Belanova, R; Sprlakova-Pukova, A; Standara, M; Janu, E; Koukalova, R; Kristek, J; Burkon, P; Kolouskova, I; Prochazka, T; Pospisil, P; Chakravarti, A; Slampa, P; Slaby, O; Kazda, T, 2020: In silico study of pseudoprogression in glioblastoma: collaboration of radiologists and radiation oncologists in the estimation of extent of high dose RT region. BIOMEDICAL PAPERS-OLOMOUC 164(3), p. 307 - 313, doi: 10.5507/bp.2019.039
• Gablo, N; Trachtova, K; Prochazka, V; Hlavsa, J; Grolich, T; Kiss, I; Srovnal, J; Rehulkova, A; Lovecek, M; Skalicky, P; Berindan-Neagoe, I; Kala, Z; Slaby, O, 2020: Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection. JOURNAL OF CLINICAL MEDICINE 9(8), doi: 10.3390/jcm9082440
• Nekvindova, J; Mrkvicova, A; Zubanova, V; Vaculova, AH; Anzenbacher, P; Soucek, P; Radova, L; Slaby, O; Kiss, I; Vondracek, J; Spicakova, A; Bohovicova, L; Fabian, P; Kala, Z; Palicka, V, 2020: Hepatocellular carcinoma: Gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450. BIOCHEMICAL PHARMACOLOGY 177, doi: 10.1016/j.bcp.2020.113912
• Drula, R; Braicu, C; Harangus, A; Nabavi, SM; Trif, M; Slaby, O; Ionescu, C; Irimie, A; Berindan-Neagoe, I, 2020: Critical function of circular RNAs in lung cancer. WILEY INTERDISCIPLINARY REVIEWS-RNA 11(5), doi: 10.1002/wrna.1592
• Polaskova, K; Merta, T; Martincekova, A; Zapletalova, D; Kyr, M; Mazanek, P; Krenova, Z; Mudry, P; Jezova, M; Tuma, J; Skotakova, J; Cervinkova, I; Valik, D; Zdrazilova-Dubska, L; Noskova, H; Pal, K; Slaby, O; Fabian, P; Kozakova, S; Neradil, J; Veselska, R; Kanderova, V; Hrusak, O; Freiberger, T; Klement, GL; Sterba, J, 2020: Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside. FRONTIERS IN ONCOLOGY 9, doi: 10.3389/fonc.2019.01531
• Barth, DA; Drula, R; Ott, L; Fabris, L; Slaby, O; Calin, GA; Pichler, M, 2020: Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 8, doi: 10.3389/fcell.2020.00828
• Machackova, T; Trachtova, K; Prochazka, V; Grolich, T; Farkasova, M; Fiala, L; Sefr, R; Kiss, I; Skrovina, M; Dosoudil, M; Berindan-Neagoe, I; Svoboda, M; Slaby, O; Kala, Z, 2020: Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy. CANCER GENOMICS & PROTEOMICS 17(3), p. 249 - 257, doi: 10.21873/cgp.20185
• Dykova, I; Blazek, R; Souckova, K; Reichard, M; Slaby, O, 2020: Spontaneous adenocarcinoma of the gas gland in Nothobranchius fishes. DISEASES OF AQUATIC ORGANISMS 137(3), p. 205 - 210, doi: 10.3354/dao03437
• Ahmad, P; Slavik, M; Trachtova, K; Gablo, NA; Kazda, T; Gurin, D; Smilek, P; Horakova, Z; Gal, B; Hermanova, M; Slampa, P; Sana, J; Slaby, O, 2020: Salivary microRNAs identified by small RNA sequencing as potential predictors of response to intensity-modulated radiotherapy in head and neck cancer patients. CELLULAR ONCOLOGY 43(3), p. 505 - 511, doi: 10.1007/s13402-020-00507-7
• Iurca, I; Tirpe, A; Zimta, AA; Moldovan, C; Gulei, D; Slaby, O; Condorelli, G; Berindan-Neagoe, I, 2020: Macrophages Interaction and MicroRNA Interplay in the Modulation of Cancer Development and Metastasis. FRONTIERS IN IMMUNOLOGY 11, doi: 10.3389/fimmu.2020.00870
• Noskova, H; Kyr, M; Pal, K; Merta, T; Mudry, P; Polaskova, K; Ivkovic, TC; Adamcova, S; Hornakova, T; Jezova, M; Kren, L; Sterba, J; Slaby, O, 2020: Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?. CANCERS 12(1), doi: 10.3390/cancers12010230
• Gojo, J; Pavelka, Z; Zapletalova, D; Schmook, MT; Mayr, L; Madlener, S; Kyr, M; Vejmelkova, K; Smrcka, M; Czech, T; Dorfer, C; Skotakova, J; Azizi, AA; Chocholous, M; Reisinger, D; Lastovicka, D; Valik, D; Haberler, C; Peyrl, A; Noskova, H; Pal, K; Jezova, M; Veselska, R; Kozakova, S; Slaby, O; Slavc, I; Sterba, J, 2020: Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities. FRONTIERS IN ONCOLOGY 9, doi: 10.3389/fonc.2019.01436
• Barth, DA; Juracek, J; Slaby, O; Pichler, M; Calin, GA, 2020: lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System. CANCERS 12(8), doi: 10.3390/cancers12082148
• Seles, M; Hutterer, GC; Fosselteder, J; Svoboda, M; Resel, M; Barth, DA; Pichler, R; Bauernhofer, T; Zigeuner, RE; Pummer, K; Slaby, O; Klec, C; Pichler, M, 2020: Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer. CANCERS 12(5), doi: 10.3390/cancers12051200
• Jabandziev, P; Pinkasova, T; Kunovsky, L; Papez, J; Jouza, M; Karlinova, B; Novackova, M; Urik, M; Aulicka, S; Slaby, O; Bohosova, J; Bajerova, K; Bajer, M; Goel, A, 2020: Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002-2017). JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION 70(5), p. 586 - 592, doi: 10.1097/MPG.0000000000002660
• Chen, BQ; Dragomir, MP; Fabris, L; Bayraktar, R; Knutsen, E; Liu, X; Tang, CY; Li, YF; Shimura, T; Ivkovic, TC; De los Santos, MC; Anfossi, S; Shimizu, M; Shah, MY; Ling, H; Shen, P; Multani, AS; Pardini, B; Burks, JK; Katayama, H; Reineke, LC; Huo, LF; Syed, M; Song, SM; Ferracin, M; Oki, E; Fromm, B; Ivan, C; Bhuvaneshwar, K; Gusev, Y; Mimori, K; Menter, D; Sen, S; Matsuyama, T; Uetake, H; Vasilescu, C; Kopetz, S; Parker-Thornburg, J; Taguchi, A; Hanash, SM; Girnita, L; Slaby, O; Goel, A; Varani, G; Gagea, M; Li, CL; Ajani, JA; Calin, GA, 2020: The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling. GASTROENTEROLOGY 159(6), p. 2146 - 2195, doi: 10.1053/j.gastro.2020.08.018
• Slaba, K; Noskova, H; Vesela, P; Tuckova, J; Jicinska, H; Honzik, T; Hansikova, H; Kleiblova, P; Stourac, P; Jabandziev, P; Slaby, O; Prochazkova, D, 2020: Novel Splicing Variant in the PMM2 Gene in a Patient With PMM2-CDG Syndrome Presenting With Pericardial Effusion: A Case Report. FRONTIERS IN GENETICS 11, doi: 10.3389/fgene.2020.561054
• Machackova, T; Vychytilova-Faltejskova, P; Souckova, K; Trachtova, K; Brchnelova, D; Svoboda, M; Kiss, I; Prochazka, V; Kala, Z; Slaby, O, 2020: MiR-215-5p Reduces Liver Metastasis in an Experimental Model of Colorectal Cancer through Regulation of ECM-Receptor Interactions and Focal Adhesion. CANCERS 12(12), doi: 10.3390/cancers12123518
• Capoor, MN; Ahmed, FS; McDowell, A; Slaby, O, 2020: Is the ´Common Cold´ Our Greatest Ally in the Battle Against SARS-CoV-2?. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY 10, doi: 10.3389/fcimb.2020.605334
• Hulstaert, E; Morlion, A; Cobos, FA; Verniers, K; Nuytens, J; Vanden Eynde, E; Yigit, N; Anckaert, J; Geerts, A; Hindryckx, P; Jacques, P; Brusselle, G; Bracke, KR; Maes, T; Malfait, T; Derveaux, T; Ninclaus, V; Van Cauwenbergh, C; Roelens, K; Roets, E; Hemelsoet, D; Tilleman, K; Brochez, L; Kuersten, S; Simon, LM; Karg, S; Kautzky-Willers, A; Leutner, M; Nohammer, C; Slaby, O; Prins, RW; Koster, J; Lefever, S; Schroth, GP; Vandesompele, J; Mestdagh, P, 2020: Charting Extracellular Transcriptomes in The Human Biofluid RNA Atlas. CELL REPORTS 33(13), doi: 10.1016/j.celrep.2020.108552
• Pichler, M; Rodriguez-Aguayo, C; Nam, SY; Dragomir, MP; Bayraktar, R; Anfossi, S; Knutsen, E; Ivan, C; Fuentes-Mattei, E; Lee, SK; Ling, H; Ivkovic, TC; Huang, GL; Huang, L; Okugawa, Y; Katayama, H; Taguchi, A; Bayraktar, E; Bhattacharya, R; Amero, P; He, WR; Tran, AM; Vychytilova-Faltejskova, P; Klec, C; Bonilla, DL; Zhang, XN; Kapitanovic, S; Loncar, B; Gafa, R; Wang, ZH; Cristini, V; Hanash, SM; Bar-Eli, M; Lanza, GN; Slaby, O; Goel, A; Rigoutsos, I; Lopez-Berestein, G; Calin, GA, 2020: Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. GUT 69(10), p. 1818 - 1831, doi: 10.1136/gutjnl-2019-318903
• Jabandziev, P; Bohosova, J; Pinkasova, T; Kunovsky, L; Slaby, O; Goel, A, 2020: The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease. INFLAMMATORY BOWEL DISEASES 26(7), p. 985 - 993, doi: 10.1093/ibd/izaa009
• Vybihal, V; Smrcka, M; Roskova, I; Kazda, T; Sprlakova-Pukova, A; Sana, J; Slaby, O; Vecera, M; Kren, L; Fadrus, P, 2020: Surgical treatment of brain metastases. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE 83(2), p. 157 - 165, doi: 10.14735/amcsnn2020157

2019

• Capoor, MN; McDowell, A; Birkenmaier, C; Ahmed, FS; Coscia, E; Raz, A; Mavrommatis, K; Fischetti, VA; Slaby, O, 2019: Letter to the Editor concerning ´Bacteria: back pain, leg pain and Modic sign: a surgical multicenter comparative study´ by Fritzell, P., Welinder-Olsson, C., Jonsson, B. et al. Eur Spine J (2019). EUROPEAN SPINE JOURNAL , doi: 10.1007/s00586-019-06237-1
• Ahmad, P; Sana, J; Slavik, M; Gurin, D; Radova, L; Gablo, NA; Kazda, T; Smilek, P; Horakova, Z; Gal, B; Hermanova, M; Slampa, P; Slaby, O, 2019: MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy. CANCER GENOMICS & PROTEOMICS 16(2), p. 139 - 146, doi: 10.21873/cgp.20119
• Capoor, MN; McDowell, A; Raz, A; Lambert, P; Slaby, O, 2019: Letter to the Editor concerning ´Low virulence bacterial infections in cervical intervertebral discs: a prospective case series´ by Chen Y, Wang X, Zhang X, et al. (Eur Spine J; 2018: doi:10.1007/s00586-018-5582-4). EUROPEAN SPINE JOURNAL 28(5), p. 1242 - 1245, doi: 10.1007/s00586-018-5671-4
• Capoor, MN; Lochman, J; McDowell, A; Schmitz, JE; Solansky, M; Zapletalova, M; Alamin, TF; Coscia, MF; Garfin, SR; Jancalek, R; Ruzicka, F; Shamie, AN; Smrcka, M; Wang, JC; Birkenmaier, C; Slaby, O, 2019: Intervertebral disc penetration by antibiotics used prophylactically in spinal surgery: implications for the current standards and treatment of disc infections (vol 28, pg 783, 2019). EUROPEAN SPINE JOURNAL 28(6), p. 1546 - 1547, doi: 10.1007/s00586-019-05991-6
• Capoor, MN; Lochman, J; McDowell, A; Schmitz, JE; Solansky, M; Zapletalova, M; Alamin, TF; Coscia, MF; Garfin, SR; Jancalek, R; Ruzicka, F; Shamie, AN; Smrcka, M; Wang, JC; Birkenmaier, C; Slaby, O, 2019: Intervertebral disc penetration by antibiotics used prophylactically in spinal surgery: implications for the current standards and treatment of disc infections. EUROPEAN SPINE JOURNAL 28(4), p. 783 - 791, doi: 10.1007/s00586-018-5838-z
• Novak, J; Machackova, T; Novakova, T; Godava, J; Hude, P; Zampachova, V; Oppelt, J; Nemec, P; Bedanova, H; Slaby, O; Bienertova-Vasku, J; Krejci, J; Spinarova, L, 2019: Identifying urinary microRNAs for heart allograft rejection monitoring using small RNA sequencing - Pilot results. EUROPEAN JOURNAL OF HEART FAILURE 21, p. 350 - 350
• Juracek, J; Piler, P; Janku, P; Radova, L; Slaby, O, 2019: Identification of microRNA signatures in umbilical cord blood associated with maternal characteristics. PEERJ 7, doi: 10.7717/peerj.6981
• Slavik, M; Shatokhina, T; Sana, J; Ahmad, P; Kazda, T; Selingerova, I; Hermanova, M; Cervena, R; Novotny, T; Burkon, P; Smilek, P; Horakova, Z; Slampa, P; Slaby, O, 2019: Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 41(4), p. 940 - 949, doi: 10.1002/hed.25533
• Krepelkova, I; Mrackova, T; Izakova, J; Dvorakova, B; Chalupova, L; Mikulik, R; Slaby, O; Bartos, M; Ruzicka, V, 2019: Evaluation of miRNA detection methods for the analytical characteristics necessary for clinical utilization. BIOTECHNIQUES 66(6), p. 277 - 284, doi: 10.2144/btn-2019-0021
• Juracek, J; Stanik, M; Vesela, P; Radova, L; Dolezel, J; Svoboda, M; Slaby, O, 2019: Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 37(3), doi: 10.1016/j.urolonc.2018.10.014
• Vecera, M; Sana, J; Oppelt, J; Tichy, B; Alena, K; Lipina, R; Smrcka, M; Jancalek, R; Hermanova, M; Kren, L; Slaby, O, 2019: Testing of library preparation methods for transcriptome sequencing of real life glioblastoma and brain tissue specimens: A comparative study with special focus on long non-coding RNAs. PLOS ONE 14(2), doi: 10.1371/journal.pone.0211978
• Hatina, J; Kripnerova, M; Houfkova, K; Pesta, M; Kuncova, J; Sana, J; Slaby, O; Rodriguez, R, 2019: Sarcoma Stem Cell Heterogeneity. STEM CELLS HETEROGENEITY - NOVEL CONCEPTS 1123, p. 95 - 118, doi: 10.1007/978-3-030-11096-3_7
• Vecera, M; Oppelt, J; Radova, L; Lipina, R; Reguli, S; Smrcka, M; Jancalek, R; Filip, M; Hermanova, M; Kren, L; Sana, J; Kopkova, A; Kovacova, J; Slaby, O, 2019: Dysregulated expression of lncRNAs in glioblastoma multiforme and their association with overall survival. CANCER RESEARCH 79(13), doi: 10.1158/1538-7445.AM2019-3575
• Kopkova, A; Sana, J; Vecera, M; Machackova, T; Fadrus, P; Kovacova, J; Slaby, O, 2019: Global analysis and validation of miRNA levels in cerebrospinal fluid of brain tumor patients. CANCER RESEARCH 79(13), doi: 10.1158/1538-7445.AM2019-1806
• Novakova, T; Machackova, T; Novak, J; Hude, P; Godava, J; Zampachova, V; Oppelt, J; Zlamal, F; Nemec, P; Bedanova, H; Slaby, O; Bienertova-Vasku, J; Spinarova, L; Krejci, J, 2019: Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing. CELLS 8(11), doi: 10.3390/cells8111400
• Barth, DA; Slaby, O; Klec, C; Juracek, J; Drula, R; Calin, GA; Pichler, M, 2019: Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma. CANCERS 11(10), doi: 10.3390/cancers11101580
• Noskova, H; Adamcova, S; Knoflickova, D; Pal, K; Grioni, A; Hornakova, T; Merta, T; Mudry, P; Pavelka, Z; Vejmelkova, K; Sterba, J; Slaby, O, 2019: Comparison of whole exome sequencing and FoundationOne Heme sequencing panel as tools for precision oncology in paediatric patients with difficult-to-treat solid tumours. ANNALS OF ONCOLOGY 30, doi: 10.1093/annonc/mdz413.102
• Esteban-Gil, A; Perez-Sanz, F; Garcia-Solano, J; Alburquerque-Gonzalez, B; Parreno-Gonzalez, MA; Legaz-Garcia, MD; Fernandez-Breis, JT; Rodriguez-Braun, E; Pimentel, P; Tuomisto, A; Makinen, M; Slaby, O; Conesa-Zamora, P, 2019: ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer. SCIENTIFIC DATA 6, doi: 10.1038/s41597-019-0198-z
• Kopkova, A; Sana, J; Machackova, T; Vecera, M; Radova, L; Trachtova, K; Vybihal, V; Smrcka, M; Kazda, T; Slaby, O; Fadrus, P, 2019: Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors. CANCERS 11(10), doi: 10.3390/cancers11101546
• Gablo, NA; Prochazka, V; Kala, Z; Slaby, O; Kiss, I, 2019: Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer. CURRENT GENOMICS 20(8), p. 569 - 580, doi: 10.2174/1389202921666191217095017
• Capoor, MN; Birkenmaier, C; Wang, JC; McDowell, A; Ahmed, FS; Br?ggemann, H; Coscia, E; Davies, DG; Ohrt-Nissen, S; Raz, A; Ruzicka, F; Schmitz, JE; Fischetti, VA; Slaby, O, 2019: A review of microscopy-based evidence for the association of Propionibacterium acnes biofilms in degenerative disc disease and other diseased human tissue. EUROPEAN SPINE JOURNAL 28(12), p. 2951 - 2971, doi: 10.1007/s00586-019-06086-y
• Braicu, C; Buse, M; Busuioc, C; Drula, R; Gulei, D; Raduly, L; Rusu, A; Irimie, A; Atanasov, AG; Slaby, O; Ionescu, C; Berindan-Neagoe, I, 2019: A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. CANCERS 11(10), doi: 10.3390/cancers11101618
• Vychytilova-Faltejskova, P; Kovarikova, AS; Grolich, T; Prochazka, V; Slaba, K; Machackova, T; Halamkova, J; Svoboda, M; Kala, Z; Kiss, I; Slaby, O, 2019: MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20(18), doi: 10.3390/ijms20184460
• Gregorova, J; Radova, L; Gablo, NA; Almasi, M; Stork, M; Slaby, O; Pour, L; Minarik, J; Sevcikova, S, 2019: MicroRNA analysis in multiple myeloma and extramedullary disease. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 19(10), p. E65 - E66, doi: 10.1016/j.clml.2019.09.103
• Koleckova, M; Kolar, Z; Ehrmann, J; Svoboda, M; Slaby, O; Bouchal, J; Bouchalova, K; Janikova, M; Srovnal, J; Radova, L, 2019: Investigation of microRNA expression profiles related tomorphological heterogeneity in triple-negative breast cancer. VIRCHOWS ARCHIV 475, p. S17 - S17
• Vychytilova-Faltejskova, P; Slaby, O, 2019: MicroRNA-215: From biology to theranostic applications. MOLECULAR ASPECTS OF MEDICINE , doi: 10.1016/j.mam.2019.03.002
• Irimie-Aghiorghiesei, AI; Pop-Bica, C; Pintea, S; Braicu, C; Cojocneanu, R; Zimta, AA; Gulei, D; Slaby, O; Berindan-Neagoe, I, 2019: Prognostic Value of MiR-21: An Updated Meta-Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC). JOURNAL OF CLINICAL MEDICINE 8(12), doi: 10.3390/jcm8122041
• Zimta, AA; Tigu, AB; Muntean, M; Cenariu, D; Slaby, O; Berindan-Neagoe, I, 2019: Molecular Links between Central Obesity and Breast Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20(21), doi: 10.3390/ijms20215364

2018

• Kopkova, A; Sana, J; Fadrus, P; Slaby, O., 2018: Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors. CLINICAL CHEMISTRY AND LABORATORY MEDICINE , doi: 10.1515/cclm-2017-0958
• Sana, J; Busek, P; Fadrus, P; Besse, A; Radova, L; Vecera, M; Reguli, S; Stollinova Sromova, L; Hilser, M; Lipina, R; Lakomy, R; Kren, L; Smrcka, M; Sedo, A; Slaby, O., 2018: Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival. SCIENTIFIC REPORTS , doi: 10.1038/s41598-018-20929-6
• Poprach, A; Fiala, O; Chloupkova, R; Melichar, B; Lakomy, R; Petrakova, K; Zemanova, M; Kopeckova, K; Slaby, O; Studentova, H; Kopecky, J; Kiss, I; Finek, J; Dusek, L; Buchler, T, 2018: Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients. ANTICANCER RESEARCH 38(1), p. 449 - 456, doi: 10.21873/anticanres.12243
• Novak, J; Machackova, T; Kafunkova, T; Mlejnek, D; Godava, J; Hude, P; Zampachova, V; Oppelt, J; Nemec, P; Bedanova, H; Slaby, O; Vasku, JB; Krejci, J; Spinarova, L, 2018: Plasmatic levels of several microRNAs are altered during acute cellular rejection in patients after heart transplantation. EUROPEAN HEART JOURNAL 39, p. 582 - 582
• Kazda, T; Kuklova, A; Belanova, R; Pospisil, P; Burkon, P; Hynkova, L; Slampa, P; Sana, J; Slaby, O; Jancalek, R, 2018: LATERALITY OF HIPOCCAMPAL METASTASES: MRI ANALYSIS OF 260 PATIENTS WITH 2595 BRAIN METASTASES. NEURO-ONCOLOGY 20, p. 307 - 307
• Kazda, T; Misove, A; Burkon, P; Pospisil, P; Hynkova, L; Selingerova, I; Dziacky, A; Belanova, R; Bulik, M; Rehak, Z; Poprach, A; Slama, O; Slampa, P; Slaby, O; Jancalek, R; Lakomy, R, 2018: Incidence of Hippocampal Metastases: Laterality and Implications for Unilateral Hippocampal Avoiding Whole Brain Radiotherapy. BIOMED RESEARCH INTERNATIONAL , doi: 10.1155/2018/2459608
• Slaby, O; McDowell, A; Bruggemann, H; Raz, A; Demir-Deviren, S; Freemont, T; Lambert, P; Capoor, MN, 2018: Is IL-1 beta Further Evidence for the Role of Propionibacterium acnes in Degenerative Disc Disease? Lessons From the Study of the Inflammatory Skin Condition Acne Vulgaris. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY 8, doi: 10.3389/fcimb.2018.00272
• Hatina, J; Kripnerova, M; Parmar, HS; Houdek, Z; Dvorak, P; Houfkova, K; Pesta, M; Kuncova, J; Sana, S; Slaby, O, 2018: Identification of candidate genes underlying soft tissue sarcoma progression using a progression series of murine fibrosarcoma cell lines. FEBS OPEN BIO 8, p. 327 - 328
• Melicharkova, K; Martincekova, A; Zapletalova, D; Kyr, M; Mazanek, P; Krenova, Z; Mudry, P; Tuma, J; Skotakova, J; Cervinkova, I; Valik, D; Zdrazilova-Dubska, L; Noskova, H; Pal, K; Slaby, O; Fabian, P; Kozakova, S; Neradil, J; Veselska, R; Kanderova, V; Hrusak, O; Freiberger, T; Klement, GL; Sterba, J, 2018: Customized, or randomized trials for relapsed refractory pediatric Burkitt lymphomas? A retrospective analysis of two clinical cases with comprehensive molecular profiling - possible explanation for different treatment outcomes after similar targeted therapies. BRITISH JOURNAL OF HAEMATOLOGY 182, p. 97 - 98
• Vychytilova-Faltejskova, P; Stitkovcova, K; Radova, L; Sachlova, M; Kosarova, Z; Slaba, K; Kala, Z; Svoboda, M; Kiss, I; Vyzula, R; Cho, WC; Slaby, O, 2018: Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 Are Promising Diagnostic Biomarkers of Colon Cancer. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 27(9), p. 1019 - 1028, doi: 10.1158/1055-9965.EPI-18-0318
• Slavik, M; Shatokhina, T; Sana, J; Ahmad, P; Hermanova, M; Kazda, T; Slampa, P; Slaby, O, 2018: CD44, EGFR and p16 expressions in oropharyngeal squamous cell cancer patients treated by IMRT.. RADIOTHERAPY AND ONCOLOGY 127, p. S1265 - S1265, doi: 10.1016/S0167-8140(18)32601-X
• Kazda, T; Dziacky, A; Burkon, P; Pospisil, P; Slavik, M; Rehak, Z; Jancalek, R; Slampa, P; Slaby, O; Lakomy, R, 2018: Radiotherapy of glioblastoma 15 years after the landmark Stupp´s trial: more controversies than standards?. RADIOLOGY AND ONCOLOGY 52(2), p. 121 - 128, doi: 10.2478/raon-2018-0023
• Karasek, P; Gablo, N; Hlavsa, J; Kiss, I; Vychytilova-Faltejskova, P; Hermanova, M; Kala, Z; Slaby, O; Prochazka, V, 2018: Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection. CANCER GENOMICS & PROTEOMICS 15(4), p. 321 - 327, doi: 10.21873/cgp.20090
• Hermanova, M; Ahmad, P; Sana, J; Slavik, M; Shatokhina, T; Slaby, O, 2018: MicroRNAs Expression Model Predicts Time to Local Recurrence in Head and Neck Squamous Cell Carcinoma. MODERN PATHOLOGY 31, p. 476 - 476
• Capoor, MN; Lambert, P; Slaby, O, 2018: Letter to the Editor concerning ´Ribosomal PCR assay of excised intervertebral discs from patients undergoing single-level primary lumbar microdiscectomy.´´ by Alamin TF, Munoz M, Zagel A, et al.: Eur Spine J 2017. EUROPEAN SPINE JOURNAL 27(2), p. 516 - 517, doi: 10.1007/s00586-017-5379-x
• Abt, D; Besse, A; Sedlarikova, L; Kraus, M; Bader, J; Silzle, T; Vodinska, M; Slaby, O; Schmid, HP; Engeler, DS; Driessen, C; Besse, L, 2018: Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir. BJU INTERNATIONAL 121(4), p. 600 - 609, doi: 10.1111/bju.14083
• Juracek, J; Peltanova, B; Dolezel, J; Fedorko, M; Pacik, D; Radova, L; Vesela, P; Svoboda, M; Slaby, O; Stanik, M, 2018: Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 22(3), p. 2033 - 2038, doi: 10.1111/jcmm.13487
• Rohleder, O; Mudry, P; Neradil, J; Noskova, H; Slaby, O; Sterba, J, 2018: Letter to Editor: FS Kaplan, et al., Early clinical observations on the use of imatinibmesylate in FOP: A report of seven cases, Bone (2017). BONE 116, p. 171 - 171, doi: 10.1016/j.bone.2018.08.003
• Kovacova, J; Poprach, A; Buchler, T; Cho, WC; Slaby, O, 2018: MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma. CLINICAL CHEMISTRY AND LABORATORY MEDICINE 56(9), p. 1426 - 1431, doi: 10.1515/cclm-2017-0861
• Hernychova, L; Nekulova, M; Kyr, M; Dosedelova, L; Capkova, L; Dvorakova, P; Jezova, M; Slaby, O; Sterba, J; Vojtesek, B; Zitterbart, K, 2018: Shotgun Proteomic Profiling in Group 3 and Group 4 Medulloblastoma. PEDIATRIC BLOOD & CANCER 65, p. S461 - S461
• Jancalek, R; Solar, P; Pospisil, P; Bulik, M; Burkon, P; Hynkova, L; Slampa, P; Sana, J; Slaby, O; Kazda, T, 2018: HIPPOCAMPAL N - ACETYLASPARTATE CONCENTRATION CORRELATES TO VERBAL MEMORY BEFORE RADIOTHERAPY FOR BRAIN METASTASES. NEURO-ONCOLOGY 20, p. 306 - 307
• Pospisil, P; Solar, P; Bulik, M; Burkon, P; Slampa, P; Sana, J; Slaby, O; Jancalek, R; Kazda, T, 2018: COMPARISON OF N-ACETYLASPARTATE CONCENTRATION DECREASE IN HIPPOCAMPAL AND WHITE BRAIN TISSUE AFTER WHOLE BRAIN RADIOTHERAPY. NEURO-ONCOLOGY 20, p. 306 - 306
• Obermannova, R; Redova-Lojova, M; Vychytilova-Faltejskova, P; Grell, P; Cho, WC; Sachlova, M; Svoboda, M; Vyzula, R; Slaby, O, 2018: Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population. ANTICANCER RESEARCH 38(6), p. 3719 - 3724, doi: 10.21873/anticanres.12651
• Gurin, D; Slavik, M; Hermanova, M; Shatokhina, T; Sana, J; Kazda, T; Selingerova, I; Ahmad, P; Smilek, P; Horakova, Z; Hendrych, M; Slampa, P; Slaby, O, 2018: Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition. JOURNAL OF ORAL PATHOLOGY & MEDICINE 47(9), p. 864 - 872, doi: 10.1111/jop.12772
• Kopkova, A; Sana, J; Fadrus, P; Machackova, T; Vecera, M; Vybihal, V; Juracek, J; Vychytilova-Faltejskova, P; Smrcka, M; Slaby, O, 2018: MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study. PLOS ONE 13(12), doi: 10.1371/journal.pone.0208580
• Vecera, M; Sana, J; Lipina, R; Smrcka, M; Slaby, O, 2018: Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 19(9), doi: 10.3390/ijms19092754
• Capoor, MN; Ruzicka, F; Sandhu, G; Rollason, J; Mavrommatis, K; Ahmed, FS; Schmitz, JE; Raz, A; Bruggemann, H; Lambert, PA; Fischetti, VA; Slaby, O, 2018: Importance of Propionibacterium acnes hemolytic activity in human intervertebral discs: A microbiological study. PLOS ONE 13(11), doi: 10.1371/journal.pone.0208144
• Sramek, M; Neradil, J; Macigova, P; Mudry, P; Polaskova, K; Slaby, O; Noskova, H; Sterba, J; Veselska, R, 2018: Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 19(9), doi: 10.3390/ijms19092599
• Kovacova, J; Juracek, J; Poprach, A; Buchler, T; Kopecky, J; Fiala, O; Svoboda, M; Slaby, O, 2018: Candidate MicroRNA Biomarkers of Therapeutic Response to Sunitinib in Metastatic Renal Cell Carcinoma: A Validation Study in Patients with Extremely Good and Poor Response. ANTICANCER RESEARCH 38(5), p. 2961 - 2965, doi: 10.21873/anticanres.12546
• Slavik, M; Ahmad, P; Sana, J; Shatokhina, T; Kazda, T; Hermanova, M; Slampa, P; Slaby, O, 2018: The Role of MicroRNAs Expression Model in Head and Neck Squamous Cell Carcinoma.. RADIOTHERAPY AND ONCOLOGY 127, p. S1264 - S1264, doi: 10.1016/S0167-8140(18)32599-4
• Klanova, B; Zlamal, F; Pohorala, A; Slaby, O; Pikhart, H; Bienertova-Vasku, J, 2018: Association of Glutathione S-Transferase Polymorphisms with Dietary Composition but Not Anthropometry in Obese as Well as Nonobese Individuals. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION 37(2), p. 87 - 92, doi: 10.1080/07315724.2017.1360807

2017

• Vychytilova-Faltejskova, P; Merhautova, J; Machackova, T; Gutierrez-Garcia, I; Garcia-Solano, J; Radova, L; Brchnelova, D; Slaba, K; Svoboda, M; Halamkova, J; Demlova, R; Kiss, I; Vyzula, R; Conesa-Zamora, P; Slaby, O, 2017: MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9. ONCOGENESIS 6, doi: 10.1038/s41389-017-0006-6
• Kiss, I; Mlcochova, J; Souckova, K; Fabian, P; Poprach, A; Halamkova, J; Svoboda, M; Vyzula, R; Slaby, O, 2017: MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX. ONCOLOGY LETTERS 14(1), p. 743 - 750, doi: 10.3892/ol.2017.6255
• Goblirsch, M; Richtig, G; Slaby, O; Berindan-Neagoe, I; Gerger, A; Pichler, M, 2017: MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy. PHARMACOGENOMICS 18(10), p. 1027 - 1038, doi: 10.2217/pgs-2017-0004
• Novak, J; Sana, J; Stracina, T; Novakova, M; Slaby, O, 2017: Doxorubicin and Liposomal Doxorubicin Differentially Affect Expression of miR-208a and let-7g in Rat Ventricles and Atria. CARDIOVASCULAR TOXICOLOGY 17(3), p. 355 - 359, doi: 10.1007/s12012-016-9393-8
• Fedorko, M; Juracek, J; Stanik, M; Svoboda, M; Poprach, A; Buchler, T; Pacikl, D; Dolezel, J; Slaby, O, 2017: Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma. BIOCHEMIA MEDICA 27(2), p. 411 - 417, doi: 10.11613/BM.2017.043
• Slaby, O; Laga, R; Sedlacek, O, 2017: Therapeutic targeting of non-coding RNAs in cancer. BIOCHEMICAL JOURNAL 474, p. 4219 - 4251, doi: 10.1042/BCJ20170079
• Jancalek, R; Hermanova, M; Slaby, O, 2017: LIMITS OF IMMUNOHISTOCHEMISTRY IN DETECTION OF IDH1 MUTATIONS IN LOW GRADE GLIOMAS. NEURO-ONCOLOGY 19, p. 181 - 181
• KOVÁŘ, D.; HUBÁLEK, J.; FOHLEROVÁ, Z.; MALÁ, A.; KALINA, M.; JIŘÍK, R.; STARČUK, Z.; SKLÁDAL, P.; HLAVÁČEK, A., 2017: Preparation and Characterisation of Highly Stable Iron Oxide Nanoparticles for Magnetic Resonance Imaging. JOURNAL OF NANOMATERIALS , p. 1 - 8, doi: 10.1155/2017/7859289; FULL TEXT
• Ahmad, P; Sana, J; Slavik, M; Slampa, P; Smilek, P; Slaby, O, 2017: MicroRNAs Involvement in Radioresistance of Head and Neck Cancer. DISEASE MARKERS , doi: 10.1155/2017/8245345
• Ondracek, J; Fadrus, P; Sana, J; Besse, A; Loja, T; Vecera, M; Radova, L; Smrcka, M; Slampa, P; Slaby, O, 2017: Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells. ANTICANCER RESEARCH 37(3), p. 1099 - 1104, doi: 10.21873/anticanres.11422
• Pichler, M; Stiegelbauer, V; Vychytilova-Faltejskova, P; Ivan, C; Ling, H; Winter, E; Zhang, XN; Goblirsch, M; Wulf-Goldenberg, A; Ohtsuka, M; Haybaeck, J; Svoboda, M; Okugawa, Y; Gerger, A; Hoefler, G; Goel, A; Slaby, O; Calin, GA, 2017: Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis. CLINICAL CANCER RESEARCH 23(5), p. 1323 - 1333, doi: 10.1158/1078-0432.CCR-16-0497
• Mudry, P; Slaby, O; Neradil, J; Soukalova, J; Melicharkova, K; Rohleder, O; Jezova, M; Seehofnerova, A; Michu, E; Veselska, R; Sterba, J, 2017: Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene. BMC CANCER 17, doi: 10.1186/s12885-017-3115-x
• Lakomy, R; Poprach, A; Bortlicek, Z; Melichar, B; Chloupkova, R; Vyzula, R; Zemanova, M; Kopeckova, K; Svoboda, M; Slaby, O; Kiss, I; Studentova, H; Juracek, J; Fiala, O; Kopecky, J; Finek, J; Dusek, L; Hejduk, K; Buchler, T, 2017: Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry. BMC CANCER 17, doi: 10.1186/s12885-017-3901-5
• Capoor, M N; Ruzicka, F; Scmitz, J E; James, GA; Machackova, T; Jancalek, R; Smrcka, M; Lipina, R; Ahmed F S; Alamin, T; Anand, N; Baird, J C; Bhatia, N; Demir-Deviren, S; Eastlack, R.K.; Fisher, S; Garfin, S R; Gogia J S; Gokaslan Z L; Kuo C C, Lee Y, Mavrommatis K, Michu E, Noskova H, Raz A, Sana J, Shamie A N, Stewart P S, Stonemetz J L, Wang J C, Witham T F; Coscia M F, Birkenmaier Ch; Fischetti V A; Slaby, O., 2017: Propionibacterium acnes biofilm is present in intervertebral discs of patients undergoing microdiscectomy. PLOS ONE 4(12), doi: 10.1371/journal.pone.0174518
• Hernychova, L; Nekulova, M; Kyr, M; Dvorakova, P; Capkova, L; Slaby, O; Pavelka, Z; Jezova, M; Vojtesek, B; Sterba, J; Zitterbart, K, 2017: Subgroup-Specific Quantitative Proteomic Profiling in Medulloblastoma. PEDIATRIC BLOOD & CANCER 64, p. S319 - S319
• Stiegelbauer, V; Vychytilova-Faltejskova, P; Karbiener, M; Pehserl, AM; Reicher, A; Resel, M; Heitzer, E; Ivan, C; Bullock, M; Ling, H; Deutsch, A; Wulf-Goldenberg, A; Adiprasito, JB; Stoeger, H; Haybaeck, J; Svoboda, M; Stotz, M; Hoefler, G; Slaby, O; Calin, GA; Gerger, A; Pichler, M, 2017: miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5. CLINICAL CANCER RESEARCH 23(17), p. 5255 - 5266, doi: 10.1158/1078-0432.CCR-17-0023
• Hruska, P; Rybecka, S; Novak, J; Zlamal, F; Splichal, Z; Slaby, O; Vasku, V; Bienertova-Vasku, J, 2017: Combinations of common polymorphisms within GSTA1 and GSTT1 as a risk factor for psoriasis in a central European population: a case-control study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 31(10), p. E461 - E463, doi: 10.1111/jdv.14266
• Veselska, R; Sramek, M; Neradil, J; Macigova, P; Mudry, P; Melicharkova, K; Slaby, O; Vanackova, J; Sterba, J, 2017: Aberrant PDGFR Signaling as a Target for Treatment of the Infantile Myofibromatosis with Sunitinib. PEDIATRIC BLOOD & CANCER 64, p. S296 - S296
• Valianatos, G; Valcikova, B; Growkova, K; Verlande, A; Mlcochova, J; Radova, L; Stetkova, M; Vyhnakova, M; Slaby, O; Uldrijan, S, 2017: A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein. PLOS ONE 12(10), doi: 10.1371/journal.pone.0185801

2016

• Merhautova, J; Vychytilova-Faltejskova, P; Demlova, R; Slaby, O, 2016: Systemic Administration of miRNA Mimics by Liposomal Delivery System in Animal Model of Colorectal Carcinoma. PHYSIOLOGICAL RESEARCH 65, p. S481 - S488
• Iliev, R; Fedorko, M; Machackova, T; Mlcochova, H; Svoboda, M; Pacik, D; Dolezel, J; Stanik, M; Slaby, O, 2016: Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma. ANTICANCER RESEARCH 36(12), p. 6419 - 6423, doi: 10.21873/anticanres.11239
• Slaby, O; Calin, GA, 2016: Non-coding RNAs in Colorectal Cancer Preface. NON-CODING RNAS IN COLORECTAL CANCER 937, p. V - V
• Slaby, O, 2016: Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection. NON-CODING RNAS IN COLORECTAL CANCER 937, p. 153 - 170, doi: 10.1007/978-3-319-42059-2_8
• Iliev, R; Stanik, M; Fedorko, M; Poprach, A; Vychytilova-Faltejskova, P; Slaba, K; Svoboda, M; Fabian, P; Pacik, D; Dolezel, J; Slaby, O, 2016: Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients. ONCOTARGETS AND THERAPY 9, doi: 10.2147/OTT.S91295
• Thorenoor, N; Faltejskova-Vychytilova, P; Hombach, S; Mlcochova, J; Kretz, M; Svoboda, M; Slaby, O, 2016: Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. ONCOTARGET 7(1), p. 622 - 637
• Iliev, R; Kleinova, R; Juracek, J; Dolezel, J; Ozanova, Z; Fedorko, M; Pacik, D; Svoboda, M; Stanik, M; Slaby, O, 2016: Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer. TUMOR BIOLOGY 37(10), p. 13385 - 13390, doi: 10.1007/s13277-016-5177-9
• Nemecek, R; Berkovcova, J; Radova, L; Kazda, T; Mlcochova, J; Vychytilova-Faltejskova, P; Slaby, O; Svoboda, M, 2016: Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy. ONCOTARGETS AND THERAPY 9, p. 4695 - 4703, doi: 10.2147/OTT.S102891
• Machackova, T; Mlcochova, H; Stanik, M; Dolezel, J; Fedorko, M; Pacik, D; Poprach, A; Svoboda, M; Slaby, O, 2016: MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition. TUMOR BIOLOGY 37(11), p. 14653 - 14658, doi: 10.1007/s13277-016-5310-9
• Besse, A; Sana, J; Lakomy, R; Kren, L; Fadrus, P; Smrcka, M; Hermanova, M; Jancalek, R; Reguli, S; Lipina, R; Svoboda, M; Slampa, P; Slaby, O, 2016: MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. TUMOR BIOLOGY 37(6), p. 7719 - 7727, doi: 10.1007/s13277-015-4654-x
• Mlcochova, H; Machackova, T; Rabien, A; Radova, L; Fabian, P; Iliev, R; Slaba, K; Poprach, A; Kilic, E; Stanik, M; Redova-Lojova, M; Svoboda, M; Dolezel, J; Vyzula, R; Jung, K; Slaby, O, 2016: Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma. SCIENTIFIC REPORTS 6, doi: 10.1038/srep31852
• Klement, GL; Arkun, K; Valik, D; Roffidal, T; Hashemi, A; Klement, C; Carmassi, P; Rietman, E; Slaby, O; Mazanek, P; Mudry, P; Kovacs, G; Kiss, C; Norga, K; Konstantinov, D; Andre, N; Slavc, I; van Den Berg, H; Kolenova, A; Kren, L; Tuma, J; Skotakova, J; Sterba, J, 2016: Future paradigms for precision oncology. ONCOTARGET 7(29), p. 46813 - 46831, doi: 10.18632/oncotarget.9488
• Sarlinova, M; Halasa, M; Mistuna, D; Musak, L; Iliev, R; Slaby, O; Mazuchova, J; Valentova, V; Plank, L; Halasova, E, 2016: miR-21, miR-221 and miR-150 Are Deregulated in Peripheral Blood of Patients with Colorectal Cancer. ANTICANCER RESEARCH 36(10), p. 5449 - 5454, doi: 10.21873/anticanres.11124
• Hezova, R; Kovarikova, A; Srovnal, J; Zemanova, M; Harustiak, T; Ehrmann, J; Hajduch, M; Sachlova, M; Svoboda, M; Slaby, O, 2016: MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus. TUMOR BIOLOGY 37(6), p. 8007 - 8018, doi: 10.1007/s13277-015-4656-8
• Ohtsuka, M; Ling, H; Ivan, C; Pichler, M; Matsushita, D; Goblirsch, M; Stiegelbauer, V; Shigeyasu, K; Zhang, XN; Chen, M; Vidhu, F; Bartholomeusz, GA; Toiyama, Y; Kusunoki, M; Doki, Y; Mori, M; Song, SM; Gunther, JR; Krishnan, S; Slaby, O; Goel, A; Ajani, JA; Radovich, M; Calin, GA, 2016: H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-beta-Catenin Signaling in Colorectal Cancer. EBIOMEDICINE 13, p. 113 - 124, doi: 10.1016/j.ebiom.2016.10.026
• Vychytilova-Faltejskova, P; Pesta, M; Radova, L; Liska, V; Daum, O; Kala, Z; Svoboda, M; Kiss, I; Slaby, O, 2016: Genome-wide microRNA Expression Profiling in Primary Tumors and Matched Liver Metastasis of Patients with Colorectal Cancer. CANCER GENOMICS & PROTEOMICS 13(4), p. 311 - 316
• Kiss, I; Mlcochova, J; Bortlicek, Z; Poprach, A; Drabek, J; Vychytilova-Faltejskova, P; Svoboda, M; Buchler, T; Batko, S; Ryska, A; Hajduch, M; Slaby, O, 2016: Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients. ANTICANCER RESEARCH 36(9), p. 4955 - 4959, doi: 10.21873/anticanres.11063
• Krutakova, M; Sarlinova, M; Iliev, R; Slaby, O; Matakova, T; Plank, L; Halasova, E, 2016: Deregulated microRNAs in peripheral blood of lung cancer patients. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 38, p. S74 - S74
• Vychytilova-Faltejskova, P; Radova, L; Sachlova, M; Kosarova, Z; Slaba, K; Fabian, P; Grolich, T; Prochazka, V; Kala, Z; Svoboda, M; Kiss, I; Vyzula, R; Slaby, O, 2016: Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer. CARCINOGENESIS 37(10), p. 941 - 950, doi: 10.1093/carcin/bgw078
• Dvorakova, P; Kyr, M; Nekulova, M; Jezova, M; Pavelka, Z; Slaby, O; Sterba, J; Vojtesek, B; Hernychova, L; Zitterbart, K, 2016: QUANTITATIVE PROTEOMIC PROFILING IN MEDULLOBLASTOMA RECAPITULATES SUBGROUPING BASED ON TRANSCRIPTIONAL PROFILES. NEURO-ONCOLOGY 18, p. 117 - 117
• Capoor, MN; Ruzicka, F; Machackova, T; Jancalek, R; Smrcka, M; Schmitz, JE; Hermanova, M; Sana, J; Michu, E; Baird, JC; Ahmed, FS; Maca, K; Lipina, R; Alamin, TF; Coscia, MF; Stonemetz, JL; Witham, T; Ehrlich, GD; Gokaslan, ZL; Mavrommatis, K; Birkenmaier, C; Fischetti, VA; Slaby, O, 2016: Prevalence of Propionibacterium acnes in Intervertebral Discs of Patients Undergoing Lumbar Microdiscectomy: A Prospective Cross-Sectional Study. PLOS ONE 11(8), doi: 10.1371/journal.pone.0161676
• Nemecek, R; Berkovcova, J; Slaby, O; Svoboda, M, 2016: Next generation sequencing mutational analysis of primary and metastatic colorectal cancer samples in relationship to efficacy of cetuximab-based therapy. ANNALS OF ONCOLOGY 27, p. 3 - 3
• Merhautova, J; Demlova, R; Slaby, O, 2016: MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers. FRONTIERS IN PHARMACOLOGY 7, doi: 10.3389/fphar.2016.00329

2015

• Thorenoor, N; Slaby, O, 2015: Small nucleolar RNAs functioning and potential roles in cancer. TUMOR BIOLOGY 36(1), p. 41 - 53, doi: 10.1007/s13277-014-2818-8
• Merhautova, J; Hezova, R; Poprach, A; Kovarikova, A; Radova, L; Svoboda, M; Vyzula, R; Demlova, R; Slaby, O, 2015: miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib. BIOMED RESEARCH INTERNATIONAL , doi: 10.1155/2015/941980
• Slaby, O; Srovnal, J; Radova, L; Gregar, J; Juracek, J; Luzna, P; Svoboda, M; Hajduch, M; Ehrmann, J, 2015: Dynamic changes in microRNA expression profiles reflect progression of Barrett´s esophagus to esophageal adenocarcinoma. CARCINOGENESIS 36(5), p. 521 - 527, doi: 10.1093/carcin/bgv023
• Hezova, R; Kovarikova, A; Srovnal, J; Zemanova, M; Harustiak, T; Ehrmann, J; Hajduch, M; Svoboda, M; Sachlova, M; Slaby, O, 2015: Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus. DIAGNOSTIC PATHOLOGY 10, doi: 10.1186/s13000-015-0280-6
• Besse, L; Sedlarikova, L; Kryukov, F; Nekvindova, J; Radova, L; Slaby, O; Kuglik, P; Almasi, M; Penka, M; Krejci, M; Adam, Z; Pour, L; Sevcikova, S; Hajek, R, 2015: Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma. PLOS ONE 10(9), doi: 10.1371/journal.pone.0137294
• Mlcochova, J; Faltejskova-Vychytilova, P; Ferracin, M; Zagatti, B; Radova, L; Svoboda, M; Nemecek, R; John, S; Kiss, I; Vyzula, R; Negrini, M; Slaby, O, 2015: MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab. ONCOTARGET 6(36), p. 38695 - 38704
• Fedorko, M; Stanik, M; Iliev, R; Redova-Lojova, M; Machackova, T; Svoboda, M; Pacik, D; Dolezel, J; Slaby, O, 2015: Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 16(10), p. 23382 - 23389, doi: 10.3390/ijms161023382
• Merhautova, J; Hezova, R; Poprach, A; Svoboda, M; Demlova, R; Slaby, O, 2015: MiRNAs associated with time to progression in metastatic renal cell carcinoma patients treated with sunitinib. EUROPEAN JOURNAL OF CANCER 51, p. S505 - S505
• Lupini, L; Bassi, C; Mlcochova, J; Musa, G; Russo, M; Vychytilova-Faltejskova, P; Svoboda, M; Sabbioni, S; Nemecek, R; Slaby, O; Negrini, M, 2015: Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients. BMC CANCER 15, doi: 10.1186/s12885-015-1752-5
• Machal, J; Novak, J; Hezova, R; Zlamal, F; Vasku, A; Slaby, O; Bienertova-Vasku, J, 2015: Polymorphism in miR-31 and miR-584 binding site in the angiotensinogen gene differentially influences body fat distribution in both sexes. GENES AND NUTRITION 10(5), doi: 10.1007/s12263-015-0488-9
• Vychytilova-Faltejskova, P; Kiss, I; Klusova, S; Hlavsa, J; Prochazka, V; Kala, Z; Mazanec, J; Hausnerova, J; Kren, L; Hermanova, M; Lenz, J; Karasek, P; Vyzula, R; Slaby, O, 2015: MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma. DIAGNOSTIC PATHOLOGY 10, doi: 10.1186/s13000-015-0272-6

2014

• Sana, J; Radova, L; Lakomy, R; Kren, L; Fadrus, P; Smrcka, M; Besse, A; Nekvindova, J; Hermanova, M; Jancalek, R; Svoboda, M; Hajduch, M; Slampa, P; Vyzula, R; Slaby, O, 2014: Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients. CARCINOGENESIS 35(12), p. 2756 - 2762, doi: 10.1093/carcin/bgu212
• Stumpfova, Z; Hezova, R; Meli, AC; Slaby, O; Michalek, J, 2014: MicroRNA Profiling of Activated and Tolerogenic Human Dendritic Cells. MEDIATORS OF INFLAMMATION , doi: 10.1155/2014/259689
• Novak, J; Kruzliak, P; Bienertova-Vasku, J; Slaby, O; Novak, M, 2014: MicroRNA-206: a Promising Theranostic Marker. THERANOSTICS 4(2), p. 119 - 133, doi: 10.7150/thno.7552
• Mlcochova, H; Hezova, R; Stanik, M; Slaby, O, 2014: Urine microRNAs as potential noninvasive biomarkers in urologic cancers. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 32(1), doi: 10.1016/j.urolonc.2013.04.011

2013

• Mlcochova, J; Faltejskova, P; Nemecek, R; Svoboda, M; Slaby, O, 2013: MicroRNAs targeting EGFR signalling pathway in colorectal cancer. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 139(10), p. 1615 - 1624, doi: 10.1007/s00432-013-1470-9
• Redova, M; Sana, J; Slaby, O, 2013: Circulating miRNAs as new blood-based biomarkers for solid cancers. FUTURE ONCOLOGY 9(3), p. 387 - 402, doi: 10.2217/FON.12.192
• POPRACH, A.;R. LAKOMY;I. SELINGEROVA;B. DOLECKOVA;O. BILEK;O. SLABY;R. HEZOVA;P. FABIAN;M. STANIK;T. PAVLIK;Z. BORTLICEK;H. MLCOCHOVA;D. TKAC;R. VYZULA;I. KISS;I. KOCAK;I. KOCAKOVA;M. SVOBODA., 2013: Epidemiologicka a klinicko-patologicka charakteristika pacientu s renalnim karcinomem: analyza 544 pripadu z jednoho centra. KLINICKA ONKOLOGIE 26, p. 114 - 123
• Bienertova-Vasku, J; Sana, J; Slaby, O, 2013: The role of microRNAs in mitochondria in cancer. CANCER LETTERS 336(1), p. 1 - 7, doi: 10.1016/j.canlet.2013.05.001
• Sevcikova, S; Kubiczkova, L; Sedlarikova, L; Slaby, O; Hajek, R, 2013: Serum miR-29a as a marker of multiple myeloma. LEUKEMIA & LYMPHOMA 54(1), p. 189 - 191, doi: 10.3109/10428194.2012.704030
• Slaby, O; Sachlova, M; Brezkova, V; Hezova, R; Kovarikova, A; Bischofova, S; Sevcikova, S; Bienertova-Vasku, J; Vasku, A; Svoboda, M; Vyzula, R, 2013: Identification of MicroRNAs Regulated by Isothiocyanates and Association of Polymorphisms Inside Their Target Sites with Risk of Sporadic Colorectal Cancer. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL 65(2), p. 247 - 254, doi: 10.1080/01635581.2013.756530
• Besse, A; Sana, J; Fadrus, P; Slaby, O, 2013: MicroRNAs involved in chemo- and radioresistance of high-grade gliomas. TUMOR BIOLOGY 34(4), p. 1969 - 1978, doi: 10.1007/s13277-013-0772-5
• Redova, M; Poprach, A; Besse, A; Iliev, R; Nekvindova, J; Lakomy, R; Radova, L; Svoboda, M; Dolezel, J; Vyzula, R; Slaby, O, 2013: MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. TUMOR BIOLOGY 34(1), p. 481 - 491, doi: 10.1007/s13277-012-0573-2
• Slaby, O, 2013: MiR-190 leads to aggressive phenotype of neuroblastoma through indirect activation of TrkB pathway. MEDICAL HYPOTHESES 80(3), p. 325 - 326, doi: 10.1016/j.mehy.2012.11.033
• NOVAK, J.;J. VINKLAREK;J. BIENERTOVA VASKU;O. SLABY., 2013: MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis. PEDIATRIC BLOOD & CANCER
• Sana, J; Besse, A; Lakomy, R; Kren, L; Kosarova, Z; Fadrus, P; Slampa, P; Smrcka, M; Vyzula, R; Slaby, O, 2013: Global expression analysis of microRNAs in paired initial and relapsed glioblastomas. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 32, p. S8 - S8
• Bienertova-Vasku, J; Mazanek, P; Hezova, R; Curdova, A; Nekvindova, J; Kren, L; Sterba, J; Slaby, O, 2013: Extension of microRNA expression pattern associated with high-risk neuroblastoma. TUMOR BIOLOGY 34(4), p. 2315 - 2319, doi: 10.1007/s13277-013-0777-0

2012

• Faltejskova, P; Besse, A; Sevcikova, S; Kubiczkova, L; Svoboda, M; Smarda, J; Kiss, I; Vyzula, R; Slaby, O, 2012: Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE 27(11), p. 1401 - 1408, doi: 10.1007/s00384-012-1461-3
• Redova, M; Poprach, A; Nekvindova, J; Iliev, R; Radova, L; Lakomy, R; Svoboda, M; Vyzula, R; Slaby, O, 2012: Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. JOURNAL OF TRANSLATIONAL MEDICINE 10, p. ´nestrankovano´ - , doi: 10.1186/1479-5876-10-55
• Faltejskova, P; Bocanek, O; Sachlova, M; Svoboda, M; Kiss, I; Vyzula, R; Slabya, O, 2012: Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer. CANCER BIOMARKERS 12(42128), p. 199 - 204, doi: 10.3233/CBM-130308
• Grell, P; Fabian, P; Khoylou, M; Radova, L; Slaby, O; Hrstka, R; Vyzula, R; Hajduch, M; Svoboda, M, 2012: Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab. INTERNATIONAL JOURNAL OF ONCOLOGY 41(4), p. 1204 - 1212, doi: 10.3892/ijo.2012.1576
• SLAMPA, P.;P. FADRUS;J. EHRMANN;Z. KOLAR;P. DUBINSKY;E. BOLJESIKOVA;A. SEDO;A. MALUCELLI;B. MALINOVA;J. RUCKA;O. SLABY;R. LAKOMY., 2012: Novinky v diagnostice a lecbe primarnich nadoru mozku – zavery mezioboroveho setkani „Winter GLIO TRACK Meeting“ 2012. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE 75/108, p. 261 - 262
• SLAMPA, P.;P. FADRUS;J. EHRMANN;Z. KOLAR;P. DUBINSKY;E. BOLJESIKOVA;A. SEDO;A. MALUCELLI;B. MALINOVA;J. RUCKA;O. SLABY;R. LAKOMY., 2012: Novinky v diagnostice a lecbe primarnich nadoru mozku - Zavery mezioboroveho setkani ´Winter GLIO TRACK Meeting´ 2012. KLINICKA ONKOLOGIE 25, p. 147 - 148
• Slaby, O; Redova, M; Poprach, A; Nekvindova, J; Iliev, R; Radova, L; Lakomy, R; Svoboda, M; Vyzula, R, 2012: Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. GENES CHROMOSOMES & CANCER 51(7), p. 707 - 716, doi: 10.1002/gcc.21957
• Svoboda, M; Sana, J; Fabian, P; Kocakova, I; Gombosova, J; Nekvindova, J; Radova, L; Vyzula, R; Slaby, O, 2012: MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. RADIATION ONCOLOGY 7, p. 195 - , doi: 10.1186/1748-717X-7-195
• Slampa, P; Fadrus, J; Kolar, Z; Dubinsky, P; Boljesikova, E; Sedo, A; Malucelli, A; Malinova, B; Rucka, J; Slaby, O; Lakomy, R, 2012: Novinky v diagnostice a léčbě primárních nádorů mozku – závěry mezioborového setkání „Winter GLIO TRACK Meeting“ 2012. ČESKÁ A SLOVENSKÁ NEUROLOGIE A NEUROCHIRURGIE 75/108, p. 261 - 262
• Slaby, O., 2012: MicroRNAs in Solid Cancer: From Biomarkers to Therapeutic Targets. NEW YORK: NOVA SCIENCE PUBLISHERS
• SVOBODA, M.;J. NAVRATIL;P. FABIAN;M. PALACOVA;J. GOMBOSOVA;L. SLAMOVA;D. PRINC;B. SYPTAKOVA;A. KUDLACEK;O. BILEK;P. POSPISIL;T. KAZDA;P. GRELL;A. POPRACH;I. SELINGEROVA;R. NENUTIL;J. JURACEK;R. HEZOVA;O. SLABY;R. VYZULA., 2012: Triple-negativni karcinom prsu: analyza souboru pacientek diagnostikovanych a/nebo lecenych v Masarykove onkologickem ustavu v letech 2004 az 2009. KLINICKA ONKOLOGIE 25, p. 188 - 198
• Faltejskova, P; Svoboda, M; Srutova, K; Mlcochova, J; Besse, A; Nekvindova, J; Radova, L; Fabian, P; Slaba, K; Kiss, I; Vyzula, R; Slaby, O, 2012: Identification and functional screening of microRNAs highly deregulated in colorectal cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 16(11), p. 2655 - 2666, doi: 10.1111/j.1582-4934.2012.01579.x
• Kren, L; Valkovsky, I; Dolezel, J; Capak, I; Pacik, D; Poprach, A; Lakomy, R; Redova, M; Fabian, P; Krenova, Z; Slaby, O, 2012: HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma. DIAGNOSTIC PATHOLOGY 7, p. 58 - 64, doi: 10.1186/1746-1596-7-58
• Slaby, O; Bienertova-Vasku, J; Svoboda, M; Vyzula, R, 2012: Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 16(1), p. 8 - 21, doi: 10.1111/j.1582-4934.2011.01359.x
• Sana, J; Hankeova, S; Svoboda, M; Kiss, I; Vyzula, R; Slaby, O, 2012: Expression Levels of Transcribed Ultraconserved Regions uc.73 and uc.388 Are Altered in Colorectal Cancer. ONCOLOGY 82(2), p. 114 - 118, doi: 10.1159/000336479
• Hezova, R; Kovarikova, A; Bienertova-Vasku, J; Sachlova, M; Redova, M; Vasku, A; Svoboda, M; Radova, L; Kiss, I; Vyzula, R; Slaby, O, 2012: Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. WORLD JOURNAL OF GASTROENTEROLOGY 18(22), p. 2827 - 2831, doi: 10.3748/wjg.v18.i22.2827
• SANA, J.;P. FALTEJSKOVA;M. SVOBODA;O. SLABY., 2012: Dlouhe nekodujici RNA a jejich vyznam u nadorovych onemocneni. KLINICKA ONKOLOGIE 25, p. 246 - 254
• Strioga, M; Viswanathan, S; Darinskas, A; Slaby, O; Michalek, J, 2012: Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal Cells. STEM CELLS AND DEVELOPMENT 21(14), p. 2724 - 2752, doi: 10.1089/scd.2011.0722
• Sana, J; Faltejskova, P; Svoboda, M; Slaby, O, 2012: Novel classes of non-coding RNAs and cancer. JOURNAL OF TRANSLATIONAL MEDICINE 10, p. ´nestrankovano´ - , doi: 10.1186/1479-5876-10-103
• AMBRUZOVA, B.;M. REDOVA;J. MICHALEK;M. SACHLOVA;O. SLABY., 2012: Nove poznatky v patogenezi Crohnovy choroby. VNITRNI LEKARSTVI 58, p. 291 - 298
• Kren, L; Fabian, P; Slaby, O; Janikova, A; Soucek, O; Sterba, J; Krenova, Z; Michalek, J; Kral, Z, 2012: Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: Possible implications. PATHOLOGY RESEARCH AND PRACTICE 208(1), p. 45 - 49, doi: 10.1016/j.prp.2011.11.004
• Svoboda, M; Sana, J; Redova, M; Navratil, J; Palacova, M; Fabian, P; Slaby, O; Vyzula, R, 2012: MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. DIAGNOSTIC PATHOLOGY 7, p. 31 - 35, doi: 10.1186/1746-1596-7-31
• SLABY, O., 2012: MikroRNA vstupuji do klinickeho testovani. KLINICKA ONKOLOGIE 25, p. 139 - 142
• Hezova, R; Bienertova-Vasku, J; Sachlova, M; Brezkova, V; Vasku, A; Svoboda, M; Radova, L; Kiss, I; Vyzula, R; Slaby, O, 2012: Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population. EUROPEAN JOURNAL OF MEDICAL RESEARCH 17, p. ´nestrankovano´ - , doi: 10.1186/2047-783X-17-17
• Slaby, O, 2012: MicroRNAs as a new class of lung cancer biomarkers. LUNG CANCER 77, p. S16 - S16, doi: 10.1016/j.lungcan.2012.05.027

2011

• Kren, L; Slaby, O; Muckova, K; Lzicarova, E; Sova, M; Vybihal, V; Svoboda, T; Fadrus, P; Lakomy, R; Vanhara, P; Krenova, Z; Sterba, J; Smrcka, M; Michalek, J, 2011: Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance?. NEUROPATHOLOGY 31(2), p. 129 - 134, doi: 10.1111/j.1440-1789.2010.01149.x
• Almasi, M; Sevcikova, S; Slaby, O; Kaisarova, P; Maisnar, V; Penka, M; Pika, T; Pour, L; Radocha, J; Scudla, V; Svachova, H; Hajek, R, 2011: Association Study of Selected Genetic Polymorphisms and Occurrence of Venous Thromboembolism in Patients With Multiple Myeloma Who Were Treated With Thalidomide. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 11(5), p. 414 - 420, doi: 10.1016/j.clml.2011.03.024
• Sana, J; Hajduch, M; Michalek, J; Vyzula, R; Slaby, O, 2011: MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 15(8), p. 1636 - 1644, doi: 10.1111/j.1582-4934.2011.01317.x
• Redova, M; Svoboda, M; Slaby, O, 2011: MicroRNAs and their target gene networks in renal cell carcinoma. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 405(2), p. 153 - 156, doi: 10.1016/j.bbrc.2011.01.019
• Lakomy, R; Sana, J; Hankeova, S; Fadrus, P; Kren, L; Lzicarova, E; Svoboda, M; Dolezelova, H; Smrcka, M; Vyzula, R; Michalek, J; Hajduch, M; Slaby, O, 2011: MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. CANCER SCIENCE 102(12), p. 2186 - 2190, doi: 10.1111/j.1349-7006.2011.02092.x
• Krenova, Z; Kren, L; Fabian, P; Slaby, O; Janikova, A; Soucek, O; Sterba, J; Michalek, J; Kral, Z, 2011: MULTIFUNCTIONAL IMMUNE-MODULATORY PROTEIN HLA-E IDENTIFIED ON BOTH TUMOR CELLS AND BACKGROUND MICROENVIRONMENT CELLS IN CLASSICAL HODGKIN LYMPHOMA: CLINICAL IMPLICATIONS. PEDIATRIC BLOOD & CANCER 57(5), p. 774 - 774
• Lakomy, R; Sana, J; Hankeova, S; Fadrus, P; Kren, L; Svoboda, M; Slaby, O, 2011: MiR-195, miR-196b, miR-181c, miR-21 expression levels and MGMT methylation status are associated with clinical outcome in glioblastoma patients. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 28, p. S71 - S71
• Svoboda, M; Navratil, J; Fabian, P; Machackova, E; Navratilova, M; Slaby, O; Grell, P; Sedo, J; Foretova, L; Nenutil, R; Vyzula, R, 2011: EPIDEMIOLOGICAL, GENETIC, HISTOLOGICAL AND CLINICAL ASPECTS OF BREAST CANCERS IN POPULATION OF CZECH WOMEN. BREAST 20, p. S49 - S50
• Slaby, O; Faltejskova, P; Hezova, R; Svoboda, M; Nemecek, R; Besse, A; Sevcikova, S; Radova, L; Vyzula, R, 2011: DETECTION OF LYMPH NODE INVOLVEMENT IN COLORECTAL CANCER PATIENTS BY ANALYSIS OF MICRORNA EXPRESSION PROFILES. ANNALS OF ONCOLOGY 22, p. v110 - v110

2010

• Slaby, O.; Jancovicova, J.; Lakomy, R.; Svoboda, M.; Poprach, A.; Fabian, P.; Kren, L.; Michalek, J.; Vyzula, R., 2010: Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy (vol 29, pg 90, 2010). JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 29
• Hezova, R; Slaby, O; Faltejskova, P; Mikulkova, Z; Buresova, I; Raja, KRM; Hodek, J; Ovesna, J; Michalek, J, 2010: microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. CELLULAR IMMUNOLOGY 260(2), p. 70 - 74, doi: 10.1016/j.cellimm.2009.10.012
• Slaby, O; Lakomy, R; Fadrus, P; Hrstka, R; Kren, L; Lzicarova, E; Smrcka, M; Svoboda, M; Dolezalova, H; Novakova, J; Valik, D; Vyzula, R; Michalek, J, 2010: MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients. NEOPLASMA 57(3), p. 264 - 269, doi: 10.4149/neo_2010_03_264
• Michalek, Jaroslav; Ocadlikova, Darina; Matejkova, Eva; Foltankova, Veronika; Dudova, Silvie; Slaby, Ondrej; Horvath, Radek; Pour, Ludek; Hajek, Roman, 2010: Individual myeloma-specific T-cell clones eliminate tumour cells and correlate with clinical outcomes in patients with multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY 148(6), p. 859 - 867
• Slaby, O; Sachlova, M; Bednarikova, M; Fabian, P; Svoboda, M; Vytopilova, S; Valik, D; Vyzula, R, 2010: Gene Expression of Somatostatin Receptor 4 Predicts Clinical Outcome of Patients with Metastatic Neuroendocrine Tumors Treated with Somatostatin Analogs. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 25(2), p. 237 - 243, doi: 10.1089/cbr.2009.0708
• Kren, L; Muckova, K; Lzicarova, E; Sova, M; Vybihal, V; Svoboda, T; Fadrus, P; Smrcka, M; Slaby, O; Lakomy, R; Vanhara, P; Krenova, Z; Michalek, J, 2010: Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: A role in innate immunity?. JOURNAL OF NEUROIMMUNOLOGY 220(1 II), p. 131 - 135, doi: 10.1016/j.jneuroim.2010.01.014
• Slaby, O; Jancovicova, J; Lakomy, R; Svoboda, M; Poprach, A; Fabian, P; Kren, L; Michalek, J; Vyzula, R, 2010: Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 29, doi: 10.1186/1756-9966-29-90

2009

• Slaby, O., Svoboda, O., Michalek, J., Vyzula, R., 2009: MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. MOLECULAR CANCER 8
• Novakova, Jana; Slaby, Ondrej; Vyzula, Rostislav; Michalek, Jaroslav, 2009: MicroRNA involvement in glioblastoma pathogenesis. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 386(1), p. 1 - 5
• Hanak, Libor; Slaby, Ondrej; Lauerova, Ludmila; Kren, Leos; Nenutil, Rudolf; Michalek, Jaroslav, 2009: Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: Methodological implications for immunotherapy. MEDICAL SCIENCE MONITOR 15(12), p. CR638 - CR643

• Studium mikrobiální dysbiózy a deregulace mikroRNA pro účely individualizace terapeutického přístupu k dětským pacientům s nespecifickými střevními záněty, , 2021 - 2024
• Celoexomové sekvenování, sekvenování genomu s nízkým pokrytím a transkriptomu pro účely precizní onkologie u dětských pacientů s vysoce rizikovými a relabovanými solidními nádory, , 2020 - 2023
• Hostitelský mikrobiom ve vztahu k rozvoji Barrettova jícnu a adenokarcinomu jícnu, , 2020 - 2023
• Excellence in research and development of non-coding RNA DIAGnostics in ONcology, Evropská unie, 2019 - 2023
• Clinical implications of intra-tumour heterogeneity in colon cancer, Ministry of Health of the CR, 2019 - 2022
• Molecular and functional characterization of colorectal cancer derived-exosomes and exosomal long non-coding RNAs, Grantová agentura ČR, 2020 - 2022
• Sekvenční FDG-PET a miRNA jako biomarker změny strategie předoperační léčby u lokálně pokročilého karcinomu žaludku a gastroesofageální junkce (17-29389A), Ministry of Health of the CR, 2017 - 2021
• Molecular portraits of major morphological components of colon tumors, Grantová agentura ČR, 2019 - 2021
• Využití močových/tkáňových mikroRNA k navýšení specificity PSA a odlišení indolentní a agresivní formy karcinomu prostaty, Ministry of Health of the CR, 2018 - 2021
• Driver mutations in cancer genome of Nothobranchius furzeri: from tumor biology to concept of experimental model of spontaneous carcinogenesis, Grantová agentura ČR, 2019 - 2021
• Identifikace cirkulujících mikroRNA umožňujících prognostickou stratifikaci a selekci pacientů nejvíce profitujících z chirurgické léčby (16-31314A), Ministry of Health of the CR, 2016 - 2019
• Validace diagnostického panelu krátkých nekódujících RNA v krevním séru pacientů s kolorektálním karcinomem s cílem umožnit jeho transfer a vývoj inovativní neinvazivní diagnostiky průmyslovým partnerem, Masarykova univerzita, 2019 - 2019
• Molekulární prognostické a prediktivní faktory u pacientů s metastatickým renálním karcinomem léčených tyrozinkinázovými inhibitory (15-34678A), Ministry of Health of the CR, 2015 - 2018
• Studium mechanizmu spojeného s nádorově supresorovou funkcí miR-215 a substituce této miRNA jako nové lečebné strategie u kolorektálního karcinomu (GA16-18257S), Grantová agentura ČR, 2016 - 2018
• Studium močových/tkáňových mikroRNA jako potenciálních biomarkerů uroteliálního karcinomu močového měchýře (15-31071A), Ministry of Health of the CR, 2015 - 2018
• Možnosti molekulárně řízené radikální radioterapie nebo radiochemoterapie dle profilu mikroRNA u pacientů se spinocelulárními karcinomy hlavy a krku (15-31627A), Ministry of Health of the CR, 2015 - 2018
• Využití mikroRNA v mozkomíšním moku pro diagnostiku mozkových nádorů (15-34553A), Ministry of Health of the CR, 2015 - 2018
• Nová úroveň molekulární taxonomie glioblastomu založená na expresních profilech dlouhých nekódujících RNA: implikace pro diagnostiku a terapii (15-33158A), Ministry of Health of the CR, 2015 - 2018
• Studium mikroRNA a genů asociovaných s procesem epiteliálně-mezenchymální tranzice jako potenciálních markerů pro predikci rizika a časný záchyt metastazování u pacientů s renálním karcinomem (NT13547-4/2012), Ministry of Health of the CR, 2012 - 2015
• Development of diagnostic panel of circulating microRNAs for non-invasive early diagnostics and follow-up of colorectal cancer patients (NT/13549), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Analysis of EGFR signalling and microRNA expression profiles in prediction of response to anti-EGFR (NT/13860), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Analýza mikroRNA v glioblastomových kmenových buňkách: predikce léčebné odpovědi a identifikace nových terapeutických cílů u pacientů s glioblastomem, Ministry of Health of the CR, 2012 - 2015
• MicroRNA analysis in glioblastoma stem cells: prediction of therapy response and identification of new therapeutic targets in glioblastoma patients (NT/13514), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Vytvoření diagnostické sady cirkulujících mikroRNA pro neinvazivní časnou diagnostiku a sledování pacientů s kolorektálním karcinomem, Ministry of Health of the CR, 2012 - 2015
• Complex characterization of molecular genetic changes in glioblastoma multiforme and its relapses, and evaluation of their possible significance in oncologic therapy and therapy effect (NT/13581), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Zaměstnáním nejlepších mladých vědců k rozvoji mezinárodní spolupráce (CZ.1.07/2.3.00/30.0037), Ministerstvo školství, mládeže a tělovýchovy ČR, 2013 - 2015
• Development of microRNA diagnostic panel for identification Barret esophagus patients at high-risk of progression to adenocarcinoma (NT13585), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2014
• Identification and functional characterization of microRNAs with predictive significance in patients with glioblastoma (NT/11214), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2013